Anti-Factor VII heavy chain antibody
产品特性
| Product Cat#: | AB-06-1637 |
| Product type: | Primary antibody |
| Antigen: | Factor VII heavy chain |
| Immunogen: | KLH conjugated synthetic peptide derived from human Factor VII heavy chain 301-400/466 |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:500-1:2500) |
| Reactivity: | Human |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | 0.01 M TBS(pH7.4) with 1% BSA; 0.03% Proclin300 and 50% Glycerol. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | Factor VII heavy chain |
| coagulation factor VII (serum prothrombin conversion accelerator) | |
| Coagulation factor VII | |
| Eptacog alfa | |
| F7 | |
| FA7_HUMAN | |
| Factor VII | |
| Factor VII light chain | |
| FVII coagulation protein | |
| OTTHUMP00000018733 | |
| OTTHUMP00000018734 | |
| Proconvertin | |
| Serum prothrombin conversion accelerator |
展开
靶标信息
Initiates the extrinsic pathway of blood coagulation. Serine protease that circulates in the blood in a zymogen form. Factor VII is converted to factor VIIa by factor Xa, factor XIIa, factor IXa, or thrombin by minor proteolysis. In the presence of tissue factor and calcium ions, factor VIIa then converts factor X to factor Xa by limited proteolysis. Factor VIIa will also convert factor IX to factor IXa in the presence of tissue factor and calcium.
产品来源
洱畔科技实验室
